Similar Posts
New reason to skip alcohol, changing weight loss goals, and what smoking does to the brain
As weight-loss medications like Ozempic and Wegovy peak in popularity moving into the New Year, semaglutide experts believe these meds could make it more likely that people will stick with their resolutions. (SEBASTIEN BOZON/AFP via Getty Images) STICKING WITH IT – Ozempic and other weight-loss drugs may strengthen New Year’s resolutions, experts say. Continue reading……
29 Physical And Emotional Ways Childhood Trauma Can Show Up In Adults, From Those Have Lived It
“When someone else makes a small mistake: ‘No worries.’ When I do: ‘You’re inferior and dangerous scum.’” View Entire Post ›
Dementia among younger people is linked to 15 factors, major study reveals
Read this article for free! Plus get unlimited access to thousands of articles, videos and more with your free account! Please enter a valid email address. By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the content, check your…
This Handheld Tool Can Make Your Disgusting Mattress A Little Cleaner
It’s accurate to assume that germs are lurking everywhere in your home, but your mattress is one particular place that harbors untold microorganisms that many of us prefer not to think about. In fact, mattresses are more disgusting than you might ever have imagined, according to Manal Mohammed, a medical microbiologist and senior lecturer at London’s University…
What It’s Really Like To Get Fillers And Implants Removed, According To Plastic Surgeons
With all the changes in cosmetic surgery trends — from lip injections to implants and filler removal — we asked plastic surgeons about the process of dissolving fillers and whether there are any risks associated with the reversals that are making headlines. This is what experts recommend that people know before getting procedures so that…
Investors see a biotech comeback in 2024 as rates fall, deal-making picks up. Stocks to watch
Many biotech stocks struggled in 2023 despite a robust year for U.S. drug approvals. As these new therapies begin treating patients, some investors see better times ahead next year. “We’ve seen a lot of innovation,” Dan Lyons, portfolio manager on the health-care team at Janus Henderson, said, explaining that he is bullish on 2024 because…
